Funding Landscape
ARPA-H Launches Two Programs to Improve Our Ability to Fight Viruses and Treat Disease
On September 29th ARPA-A launched the Resilient Extended Automatic Cell Therapies (REACT) program and the Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) program.
The REACT program aims to overcome the problems surrounding medication non-adherence by creating two different—but related—bioelectronic devices capable of treating chronic conditions remotely. These devices will be implanted in patients during minor outpatient surgery and will interface with a simple software platform or app that allows users to track their condition directly. Hybrid Proposers’ Day: November 16, 2023, 10:30 AM – 7:30 PM EST (8:30 AM – 5:30 PM MST) in Denver, CO and virtually.
Details
The APECx program is focused on three areas: high-throughput biochemical analysis and protein engineering, protein modeling toolkit development for antigen design, and translational candidate development and clinical evaluation. Hybrid Proposers’ Day: November 17, 2023, 8:30 AM - 5:00 PM MST (10:30 AM – 7:00 PM EST) in Denver, CO and virtually see page below to register.
Details